25-hydroxycholesterol has been researched along with Injury, Ischemia-Reperfusion in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, Q; Liu, Z; Luo, J; Xiong, Y; Ye, Q | 1 |
| Dai, Q; Kong, C; Li, S; Lin, F; Liu, X; Rao, S; Wang, J; Wang, L; Yao, X; Zhao, Z | 1 |
2 other study(ies) available for 25-hydroxycholesterol and Injury, Ischemia-Reperfusion
| Article | Year |
|---|---|
25-Hydroxycholesterol mitigates hepatic ischemia reperfusion injury via mediating mitophagy.
Topics: Adenine; Alanine Transaminase; Animals; Apoptosis; Aspartate Aminotransferases; Disease Models, Animal; Hydroxycholesterols; Liver Diseases; Male; Mitophagy; NLR Family, Pyrin Domain-Containing 3 Protein; Protective Agents; Protein Kinases; Rats, Sprague-Dawley; Reperfusion Injury; Ubiquitin-Protein Ligases | 2021 |
25-Hydroxycholesterol protecting from cerebral ischemia-reperfusion injury through the inhibition of STING activity.
Topics: Animals; Autophagy; Humans; Hydroxycholesterols; Infarction, Middle Cerebral Artery; Male; Membrane Proteins; Mice; Mice, Inbred C57BL; Protective Agents; Reperfusion Injury; TOR Serine-Threonine Kinases | 2021 |